Abstract

The platelet high affinity binding site for thrombin appears to be described by a classical receptor-ligand interaction that is distinct from the platelet thrombin receptor/substrate, PAR-1. However, the identification and function of the high affinity binding site with respect to its physiological importance have continued to elude investigators. Prior studies using two mutant thrombins suggested that thrombin interaction with the platelet high affinity binding site is mediated through an extensive portion of the thrombin molecule involving residues within the substrate binding pocket and the anion binding exosite (Leong, L., Henriksen, R. A., Kermode, J. C., Rittenhouse, S. E., and Tracy, P. B. (1992) Biochemistry 31, 2567-2575) and may mimic a thrombin-hirudin interaction. To test this hypothesis, an anti-hirudin peptide antibody (anti-hirpeptide Ab) was raised against a peptide mimicking the COOH terminus of hirudin. The Ab recognized adherent platelets and those in suspension as determined by enzyme-linked immunosorbent assay and immunofluorescence microscopy, respectively. 125I-Thrombin binding to platelets was inhibited in the presence of the anti-hirpeptide Ab in a dose-dependent manner with maximal inhibition >90%. Analyses of data from binding studies of 125I-thrombin to platelets at a fixed Ab concentration indicated that the anti-hirpeptide Ab inhibited the high affinity binding interaction exclusively. In addition, thrombin-induced increases in platelet [Ca2+]i were enhanced by blocking the high affinity binding site with the Ab due to redistribution of the agonist to PAR-1. Thrombin Quick I-induced platelet calcium mobilization was unaffected by the presence of the Ab, consistent with the inability of thrombin Quick I to bind to the high affinity site. Even though glycoprotein (GP) Ib contains a hirudin-like region within the alpha subunit, the postulated high affinity binding site, direct binding of 125I-thrombin could not be demonstrated to transfected Chinese hamster ovary and L cells expressing the GP Ib-IX-V complex. Furthermore, an anti-GP Ib Ab, raised to the peptide region proposed as the thrombin high affinity site, did not enhance thrombin-induced platelet calcium mobilization. The anti-hirpeptide Ab recognized a population of platelet membrane proteins distinct from PAR-1 and GP Ib by three-color immunofluorescence using confocal microscopy. These combined studies demonstrate that the high affinity binding site for thrombin is a unique platelet protein distinct from GP Ib which modulates the effective thrombin concentration localized at the human platelet surface.

Highlights

  • High affinity, dissociable binding of thrombin to human platelets has been demonstrated and described by several laboratories [1,2,3,4,5]

  • Having shown that the anti-hirpeptide Ab recognized platelets, we examined its ability to inhibit the dissociable equilibrium and high affinity binding of 125I-thrombin to platelets. 125I-Thrombin (1 nM) binding to platelets (3 ϫ 108/ml was assessed over a range of anti-hirpeptide Ab concentrations (0 –2 ␮M) (Fig. 2)

  • We have presented data that demonstrate that the platelet high affinity binding site is a unique platelet membrane protein

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—Taipan snake venom, potato apyrase, Sephadex G-25– 150, prostaglandin E1, o-phenylenediamine dihydrochloride, 1,3,4,6tetrachloro-3␣,6␣-diphenylglycouril, and digitonin (50% purity) were purchased from Sigma. Active site-blocked thrombin (FPR-thrombin) was prepared using D-Phe-Pro-Arg chloromethyl ketone as described previously [1, 14]. RNPNDGDFEEIPEEYLQNE was synthesized manually as a peptide amide using 4-methylbenzhydralamine and t-butyloxycarbonyl-blocked amino acids with an additional COOH-terminal cysteine for coupling as described previously [22]. Peptides representing the hirudin-like regions found in PAR-1 and platelet GP Ib␣ were synthesized according to the same procedure. Three rabbit anti-peptide antisera were prepared by Cocalico Biologicals (Reamstown, PA) according to our supplied protocol [14]. Immunoglobulins, both nonimmune and specific, were purified using protein A immobilized to Sepharose 4B.

IgG were
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.